-
公开(公告)号：US20200093505A1
公开(公告)日：2020-03-26
申请号：US16683071
申请日：2019-11-13
申请人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI , Brice Arnault DE LA MENARDIERE , Clayton Miles BALDWIN , Jason Michael MILLER
发明人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI , Brice Arnault DE LA MENARDIERE , Clayton Miles BALDWIN , Jason Michael MILLER
IPC分类号： A61B17/3207 , A61B8/12 , A61B8/00 , A61B8/08 , A61B17/32 , A61B17/22 , A61N7/02 , A61B18/14 , A61M25/09
摘要： Methods and devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation. The methods may be performed using an ultrasound ablation catheter. The methods may also include imaging using at least one ultrasound imaging catheter.
-
2.发明申请CAROTID BODY ABLATION WITH A TRANSVENOUS ULTRASOUND IMAGING AND ABLATION CATHETER 审中-公开具有超声波超声成像和吸收导管的CAROTID身体吸收公开(公告)号：US20160374710A1
公开(公告)日：2016-12-29
申请号：US15263174
申请日：2016-09-12
申请人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI , Brice Arnault DE LA MENARDIERE , Clayton Miles BALDWIN , Jason MILLER
发明人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI , Brice Arnault DE LA MENARDIERE , Clayton Miles BALDWIN , Jason MILLER
IPC分类号： A61B17/32 , A61B17/3207 , A61B8/08 , A61B8/12 , A61B8/00
CPC分类号： A61B17/3207 , A61B8/0891 , A61B8/12 , A61B8/445 , A61B8/481 , A61B8/54 , A61B17/2202 , A61B17/320068 , A61B17/3478 , A61B18/1492 , A61B18/24 , A61B2017/00106 , A61B2017/00225 , A61B2017/0023 , A61B2017/00256 , A61B2017/00296 , A61B2017/003 , A61B2017/22024 , A61B2017/22028 , A61B2017/22058 , A61B2017/22062 , A61B2017/22069 , A61B2017/320044 , A61B2017/320069 , A61B2017/320071 , A61B2017/320084 , A61B2018/00023 , A61B2018/00404 , A61B2018/00577 , A61B2018/1425 , A61B2018/1475 , A61B2034/2063 , A61B2034/2065 , A61B2090/3782 , A61B2090/3784 , A61B2217/007 , A61M25/09 , A61N7/022 , A61N2007/0052
摘要： Methods and devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation. The methods may be performed using an ultrasound ablation catheter. The methods may also include imaging using at least one ultrasound imaging catheter.
摘要翻译： 用于评估和治疗患有交感神经介导的疾病的患者的方法和装置，通过减少化学传感器通过颈动脉体消融对输入神经系统的输入，涉及增加的外周化学反应和增强的交感神经紧张。 该方法可以使用超声消融导管进行。 所述方法还可以包括使用至少一个超声成像导管的成像。
-
3.发明申请CAROTID SEPTUM ABLATION WITH ULTRASOUND IMAGING AND ABLATION CATHETERS 审中-公开超声波成像和超声波吸收的CAROTID SEPTUM吸收公开(公告)号：US20160338724A1
公开(公告)日：2016-11-24
申请号：US15069531
申请日：2016-03-14
申请人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI
发明人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI
CPC分类号： A61M25/09 , A61B8/0891 , A61B8/12 , A61B8/445 , A61B17/2202 , A61B18/1492 , A61B18/24 , A61B2017/00106 , A61B2017/00256 , A61B2017/003 , A61B2017/22024 , A61B2017/22028 , A61B2017/22058 , A61B2017/22062 , A61B2017/22069 , A61B2017/320044 , A61B2017/320069 , A61B2017/320071 , A61B2018/00023 , A61B2018/00404 , A61B2018/00577 , A61B2018/1425 , A61B2018/1475 , A61B2034/2063 , A61B2034/2065 , A61B2090/3782 , A61B2090/3784 , A61N7/022
摘要： Methods and devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation.
摘要翻译： 用于评估和治疗患有交感神经介导的疾病的患者的方法和装置，通过减少化学传感器通过颈动脉体消融对输入神经系统的输入，涉及增加的外周化学反应和增强的交感神经紧张。
-
4.发明申请CAROTID BODY ABLATION WITH A TRANSVENOUS ULTRASOUND IMAGING AND ABLATION CATHETER 有权具有超声波超声成像和吸收导管的CAROTID身体吸收公开(公告)号：US20150257779A1
公开(公告)日：2015-09-17
申请号：US14656635
申请日：2015-03-12
申请人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI
发明人： Yegor D. SINELNIKOV , Zoar Jacob ENGELMAN , Mark GELFAND , Martin M. GRASSE , Timothy A. KOSS , Michael Brick MARKHAM , Kenneth M. MARTIN , Veijo T. SUORSA , Miriam H. TAIMISTO , Xian WEI
CPC分类号： A61B8/12 , A61B8/0841 , A61B8/0891 , A61B8/445 , A61B8/4477 , A61B8/481 , A61B8/488 , A61B2018/00023 , A61B2018/00029 , A61B2090/0472 , A61B2090/378 , A61B2090/3782 , A61B2090/3784 , A61B2090/3925 , A61B2090/3983 , A61N7/022
摘要： Methods and devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation.
摘要翻译： 用于评估和治疗患有交感神经介导的疾病的患者的方法和装置，通过减少化学传感器通过颈动脉体消融对输入神经系统的输入，涉及增加的外周化学反应和增强的交感神经紧张。
-
5.发明申请ENDOVASCULAR CATHETERS FOR TRANS-SUPERFICIAL TEMPORAL ARTERY TRANSMURAL CAROTID BODY MODULATION 审中-公开用于超临界流体动力学转运体内调节的血管内镜公开(公告)号：US20140243809A1
公开(公告)日：2014-08-28
申请号：US14188452
申请日：2014-02-24
申请人： Mark GELFAND , Howard LEVIN , Charles LENNOX , Marcus W. WILBORN , Paul A. SOBOTKA , Zoar Jacob ENGELMAN , Martin M. GRASSE , Mark S. LEUNG
发明人： Mark GELFAND , Howard LEVIN , Charles LENNOX , Marcus W. WILBORN , Paul A. SOBOTKA , Zoar Jacob ENGELMAN , Martin M. GRASSE , Mark S. LEUNG
IPC分类号： A61B18/14
CPC分类号： A61B18/1492 , A61B18/16 , A61B2018/00214 , A61B2018/00279 , A61B2018/00285 , A61B2018/00404 , A61B2018/00577 , A61B2018/1253 , A61B2018/126 , A61B2018/1467 , A61B2018/1475 , A61B2018/1497 , A61B2218/002 , A61N7/022
摘要： Methods, devices, and systems for carotid body modulation via accessing a target site with an endovascular approach through a superficial temporal artery.
摘要翻译： 用于通过浅表颞动脉通过血管内途径进入目标部位进行颈动脉体调节的方法，装置和系统。
-
6.发明申请公开(公告)号：US20220257315A1
公开(公告)日：2022-08-18
申请号：US17452305
申请日：2021-10-26
IPC分类号： A61B18/14
摘要： Apparatuses and methods for treating a heart failure patient by ablating a nerve of the thoracic splanchnic sympathetic nervous system to increase venous capacitance and reduce pulmonary blood pressure. A method comprising: inserting a catheter into a vein adjacent the nerve, applying stimulation energy and observing hemodynamic effects, applying ablation energy and observing hemodynamic effects, applying simulation energy after the ablation and observing hemodynamic effects and monitoring for presence of the lung in the ablation zone. An alternative method comprising: inserting a catheter into a vein adjacent the nerve, detecting that lung tissue is a safe distance from an ablation zone, and delivering ablation energy to the target nerve when lung tissue is a safe distance from the ablation zone.
-
公开(公告)号：US20200179047A1
公开(公告)日：2020-06-11
申请号：US16793698
申请日：2020-02-18
申请人： Dorin PANESCU , Andrew WU , Zoar Jacob ENGELMAN , Mark GELFAND , Mark S. LEUNG , Howard LEVIN
发明人： Dorin PANESCU , Andrew WU , Zoar Jacob ENGELMAN , Mark GELFAND , Mark S. LEUNG , Howard LEVIN
IPC分类号： A61B18/14
摘要： Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
-
公开(公告)号：US20190183569A1
公开(公告)日：2019-06-20
申请号：US16222823
申请日：2018-12-17
申请人： Dorin PANESCU , Andrew WU , Zoar Jacob ENGELMAN , Mark GELFAND , Mark S. LEUNG , Howard LEVIN
发明人： Dorin PANESCU , Andrew WU , Zoar Jacob ENGELMAN , Mark GELFAND , Mark S. LEUNG , Howard LEVIN
IPC分类号： A61B18/14
摘要： Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
-
公开(公告)号：US20130303876A1
公开(公告)日：2013-11-14
申请号：US13852895
申请日：2013-03-28
申请人： Mark GELFAND , Howard LEVIN , Zoar Jacob ENGELMAN , Marat FUDIM
发明人： Mark GELFAND , Howard LEVIN , Zoar Jacob ENGELMAN , Marat FUDIM
CPC分类号： A61B18/00 , A61B5/02 , A61B18/02 , A61B18/0206 , A61B18/12 , A61B18/1477 , A61B18/1492 , A61B18/1815 , A61B18/20 , A61B18/24 , A61B2018/00011 , A61B2018/0022 , A61B2018/00285 , A61B2018/00351 , A61B2018/00404 , A61B2018/00434 , A61B2018/00511 , A61B2018/00577 , A61B2018/00648 , A61B2018/0066 , A61B2018/00815 , A61B2018/00821 , A61B2018/00898 , A61B2018/0212 , A61B2018/0262 , A61B2018/1425 , A61B2018/1861 , A61N1/0551 , A61N1/36057 , A61N7/02 , A61N7/022
摘要： Planning for and/or assessment of an ablation procedure on one or both carotid bodies or carotid body chemoreceptors or carotid body nerves to treat patients having a sympathetically mediated cardiac, metabolic, and pulmonary disease (e.g. hypertension, CHF, diabetes, sleep disordered breathing) resulting from peripheral chemoreceptor hypersensitivity, carotid body hyperactivity, high carotid body afferent nerve signaling or heightened sympathetic activation.
摘要翻译： 规划和/或评估一个或两个颈动脉体或颈动脉体化学感受器或颈动脉体神经的消融过程，以治疗患有交感神经介导的心脏，代谢和肺部疾病（例如高血压，CHF，糖尿病，睡眠呼吸紊乱） 由外周化学感受器超敏反应，颈动脉体多动症，高颈动脉体传入神经信号传导或增强的交感神经激活引起。
-
公开(公告)号：US20160324563A1
公开(公告)日：2016-11-10
申请号：US15214222
申请日：2016-07-19
申请人： Mark GELFAND , Howard LEVIN
发明人： Mark GELFAND , Howard LEVIN
CPC分类号： A61B18/0218 , A61B18/1492 , A61B18/18 , A61B2018/0022 , A61B2018/00267 , A61B2018/00279 , A61B2018/00285 , A61B2018/00291 , A61B2018/00404 , A61B2018/00577 , A61B2018/00589 , A61B2018/00714 , A61B2018/00791 , A61B2018/0212 , A61B2018/0225 , A61B2018/0293 , A61B2018/1407 , A61B2018/1425 , A61B2018/1475 , A61B2090/3784 , A61M25/0082
摘要： Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.
摘要翻译： 用于治疗患有交感神经介导的疾病的患者的系统，装置和方法至少部分地与增加的外周化学反应或增强的交感神经激活相关联。 治疗包括消融一种或多种外周化学感受器或相关传入神经以减少或消除来自外周化学感受器的传入神经信号。
-
-
-
-
-
-
-
-
-
搜索结果
18 条记录 (耗时 0.055 秒)
